150mg Erlonat Erlotinib Tablets

150mg Erlonat Erlotinib Tablets Specification

Salt Composition
Erlotinib 150 mg

Dosage Form
Tablet

Indication
Non-small cell lung cancer

Feature
Prescribed anticancer agent

Application
Oncology treatment

Physical Color/Texture
White to off-white, film-coated

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, dry place

Shelf Life
24 months

Administration Route
Oral use

Prescription
Required

Manufactured By
Natco Pharma Ltd.

Strength
150 mg

Film-Coated
Yes

Packaging
Box of 30 tablets

150mg Erlonat Erlotinib Tablets Trade Information

Minimum Order Quantity
5000 Boxes

Supply Ability
500 Boxes Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About 150mg Erlonat Erlotinib Tablets

Erlonat 150mg Erlotinib Tablets, manufactured by Natco Pharma Ltd., deliver exceptional oncological support in the fight against non-small cell lung cancer. With a dominant reputation built on favorable reviews, these film-coated, white to off-white tablets are offered in a secure box of 30 for convenient oral administration. Reserve your box now and benefit from considerable discounts available for exporters, suppliers, and traders across India. As a towering defender in cancer care, Erlonat ensures reliable performance through its high-grade Erlotinib 150mg composition and outstanding clinical efficacy. Prescription required.

Application & Features of Erlonat 150mg Erlotinib Tablets

Erlonat 150mg Erlotinib Tablets are designed for oral intake, offering a straightforward application method for oncology patients. Featuring a film-coated exterior, these tablets are easy to swallow and ensure controlled release of medication. They are prescribed exclusively for non-small cell lung cancer, delivering an odorless, white to off-white tablet that is gentle on the digestive surface. With its precise salt composition, Erlonat upholds quality standards and provides consistent therapeutic benefits.

Certifications, Exchange Policy & Supply Capability

Erlonat 150mg Erlotinib Tablets are manufactured in compliance with strict pharmaceutical certifications, guaranteeing both safety and potency. Flexible quotation options and transparent payment terms make the purchasing process efficient. In case of product dissatisfaction, the exchange policy ensures hassle-free replacement. Our robust supply ability fulfills bulk orders promptly, while competitive charge rates further enhance value for global exporters, suppliers, and traders seeking uninterrupted oncology medicine distribution.

FAQ's of 150mg Erlonat Erlotinib Tablets:

Q: How should Erlonat 150mg Erlotinib Tablets be administered?

A: Erlonat 150mg Erlotinib Tablets should be taken orally as directed by your healthcare provider, usually once daily, with or without food, and always with a prescription.

Q: What are the special features of Erlonat 150mg Tablets?

A: These tablets are film-coated for easier swallowing, possess an odorless quality, and are manufactured by Natco Pharma Ltd. with strict adherence to pharmaceutical standards, ensuring quality and efficacy for oncology treatment.

Q: When can I expect to receive my bulk order of Erlonat Tablets?

A: Bulk supplies can be dispatched promptly, thanks to our robust supply ability. Delivery timelines may vary based on location and order size; please request a quotation for an accurate shipping schedule.

Q: Where should I store Erlonat 150mg Tablets after purchase?

A: The tablets should be stored in a dry place, below 30C, to maintain their potency and extend their 24-month shelf life.

Q: What is the process for exchanging the product if there is an issue?

A: If you encounter any concerns, contact our support team. We follow a straightforward exchange policy to facilitate hassle-free replacements, ensuring customer satisfaction.

Q: What are the primary benefits of using Erlonat 150mg Erlotinib Tablets?

A: Erlonat 150mg provides targeted oncological therapy for non-small cell lung cancer, offering patients a reliable, clinically proven treatment developed by a leading pharmaceutical manufacturer.

Tell us about your requirement